// App-Quantinova.ai

THU0300 : RISK FACTORS FOR ADVERSE PREGNANCY OUTCOME IN FIRST-LINE TREATED PREGNANCIES IN ANTIPHOSPHOLIPID ANTIBODIES-POSITIVE WOMEN ACCORDING TO DIFFERENT TREATMENT STRATEGIES: RESULTS FROM OUR 30 YEAR-EXPERIENCE PREGNANCY CLINIC

Researchers

Presenter

  • M.G. Lazzaroni

Principal Investigators

  • L. Andreoli

  • F. Lupoli

  • E. Aggogeri

  • E. Bettiga

  • S. Zatti

  • A. Lojacono

  • F. Ramazzotto

  • M. Fredi

  • A. Tincani

Medical Centers

  • Obstetrics and Gynecology, Spedali Civili and University of Brescia, Brescia, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Antiphospholipid syndrome

  • Spontaneous preterm delivery

  • HELLP syndrome

  • Preeclampsia

  • Spontaneous abortion

  • Venous thrombosis

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Aspirin

  • Albyl-E

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved